ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Emerging Immunotherapy in Advanced Renal Cell Carcinoma. – UroToday

Emerging Immunotherapy in Advanced Renal Cell Carcinoma.UroTodayImmunotherapy has recently catapulted to the forefront of treatments for patients with solid tumors. Given its inherent immunogenic properties, renal cell carcinoma (RCC) has historically … Continue reading

2017-09-22 Michael Zand NEWS

A cancer patient desperately needs a stem-cell transplant. But the US won’t grant the donor a visa. – The Lily

Continue reading

2017-09-22 Michael Zand NEWS

$11.6M NIH grant funds study of stem cells and heart disease – Temple University News


The Lily

A cancer patient desperately needs a stem–cell transplant. But the US won’t grant the donor a visa.
The Lily
Doctors told Helen’s family the patient needed a lifesaving stem cell transplant. The procedure required as close of a genetic match to Helen as possible. Her three sisters — all living in Vietnam — were the best bet. Doctors could proceed if they …

Continue reading

2017-09-22 Michael Zand NEWS

Sustained Molecular Remissions Reported in Patients With Relapsed/Refractory CLL After CD19 CAR-T Infusion – Targeted Oncology

Targeted OncologySustained Molecular Remissions Reported in Patients With Relapsed/Refractory CLL After CD19 CAR-T InfusionTargeted OncologyAbout 71% of patients (17 of 24) with chronic lymphocytic leukemia (CLL) exhibited an overall response (complete… Continue reading

2017-09-22 Michael Zand NEWS

Sustained Molecular Remissions Reported in Patients With Relapsed/Refractory CLL After CD19 CAR-T Infusion – Targeted Oncology

Targeted OncologySustained Molecular Remissions Reported in Patients With Relapsed/Refractory CLL After CD19 CAR-T InfusionTargeted OncologyAbout 71% of patients (17 of 24) with chronic lymphocytic leukemia (CLL) exhibited an overall response (complete… Continue reading

2017-09-22 Michael Zand NEWS

‘Labyrinth’ chip could help monitor aggressive cancer stem cells – Science Daily

$11.6M NIH grant funds study of stem cells and heart disease
Temple University News
The multimillion dollar grant, awarded under the NIH’s National Heart, Lung and Blood Institute, will fund a project aimed at better understanding the regenerative capabilities of stem cell-derived microvesicles known as exosomes. Professor of …

Continue reading

2017-09-22 Michael Zand NEWS

Immunotherapy, Seeking a Cure With Caution – Curetoday.com

Curetoday.comImmunotherapy, Seeking a Cure With CautionCuretoday.comSo while immunotherapies offer many promising things and come with the potential for incredible reward, they can also come with a cost. I think that caution is important as we begin do… Continue reading

2017-09-22 Michael Zand NEWS

High Gene Therapy Costs Trigger Call for New Payment Models – Genetic Engineering & Biotechnology News

‘Labyrinth’ chip could help monitor aggressive cancer stem cells
Science Daily
Cancer stem cells are fluid in their gene expression, transitioning from stem-like cells that are good at surviving in the blood to more ordinary cell types that are better at growing and dividing. Conventional cell targeting, by grabbing proteins …

and more »

Continue reading

2017-09-22 Michael Zand NEWS
  • 1
  • …
  • 1,160
  • 1,161
  • 1,162
  • 1,163
  • 1,164
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Bloomberg

High Gene Therapy Costs Trigger Call for New Payment Models
Genetic Engineering & Biotechnology News
The six-figure prices of new gene therapies will require payers, pharma companies, policymakers, and pharmacy benefit managers (PBMs) to develop new payment models that ensure patient access while reflecting the value delivered by the new treatments …
Novartis’s $475000 Price on Cancer Therapy Meets ResistanceBloomberg

all 2 news articles »